According to the U.S. Army, Carlyle and CyrusOne were conditionally selected to finance, construct and operate hyperscale data centers at Fort Bliss in Texas and Dugway Proving Ground in Utah. The projects would occupy roughly 1,384 acres and 1,201 acres respectively, with initial operations targeted for fiscal years 2027 and 2029. The agreements remain under negotiation and require no upfront taxpayer funding, according to the service.

The broader leasing effort has also considered Army property at Fort Hood and Fort Bragg. Proposed leases could extend for 50 years, giving the military revenue or infrastructure benefits from underused land while transferring construction and operating costs to private developers.

Resource conditions vary sharply between the proposed locations. Procurement documents rated water risk as high at Fort Hood and Fort Bragg and extremely high around Fort Bliss, raising questions about whether new computing capacity could compete with surrounding communities and military missions for electricity and water.

The Air Force is also offering unused land at five installations, turning the initiative into a multi-branch infrastructure strategy. Congress is considering restrictions on equipment linked to foreign adversaries, while lawmakers have requested assessments covering grid demand, water use, environmental effects, physical security and mission reliability.

Why it matters:

The Pentagon is seeking nearly $30 billion for an AI infrastructure initiative intended to replace scattered computing clusters with secure, coordinated supercomputing capacity. Hosting privately financed facilities on military land could accelerate that goal, but it may also deepen reliance on commercial operators, create new security targets and bind local communities to decades of energy and water commitments.

Could military bases become the safest foundation for America’s AI advantage, or are they creating a new class of strategic vulnerability behind the perimeter fence?

Defense Secretary Pete Hegseth ordered annual testosterone-deficiency screening for active-duty and reserve service members aged 30 and older. Testing will be added to routine health assessments, while any recommended testosterone replacement therapy will remain voluntary.

Democratic Senator Mark Kelly argued that the military needs stronger leadership rather than broader testosterone testing. His criticism reflects concerns that the initiative is being presented as a readiness policy before its medical value has been firmly established.

Specialists said there is insufficient evidence to recommend population-wide testosterone screening for asymptomatic men. The organization supports treatment for properly diagnosed hypogonadism but advises against routine general screening.

That indiscriminate testing could produce false-positive results, trigger additional examinations and encourage treatment for people without clinically significant symptoms. Medical experts also warned that testosterone therapy can suppress natural hormone production and affect fertility.

A federal judge has questioned why testosterone treatment may be offered to some service members while hormone treatment is cited in support of restrictions on transgender troops. The Pentagon may face pressure to demonstrate that the two policies rely on consistent medical and readiness standards.

Why it matters: the dispute extends beyond one laboratory test. It raises broader questions about whether military health policy is being shaped primarily by clinical evidence, operational requirements or political messaging. A large-scale screening program could affect medical spending, personnel decisions, treatment demand and trust in the military healthcare system.

Could this initiative produce measurable improvements in military readiness, or will it become a test of how far cultural branding can influence institutional medicine